The goal of this clinal trial is to compare the effectiveness of nurse-led teleconsultation with usual care (intervention group) on psychological distress in patients with primary malignant tumors of the central nervous system between diagnosis and first anti-cancer treatment, versus usual care alone (control group).
Participants will be randomized into two groups :
* group A) intervention: usual care + nurse teleconsultation for psychological support * group B) control: usual care alone
Enrolment = Day0 (D0)
Participants will :
* groups A and B: D0: complete 4 questionnaires (Quality of Life, Screening for Distress, Screening for Anxiety and Depression, Social Support Questionnaire) * Group A : D0+2/4 das : nursing teleconsultation for psychological support * Groups A and B: D0+10days : telephone call to complete the same 4 questionnaires as at inclusion * Group A : D0+15days: semi-directive interview, at home, for voluntary patients.
aged 18 and over
being treated for a primary malignant tumor of the central nervous system (positive biopsy)
with a Mini-Mental State score greater than 24
not receiving first-line treatment (chemotherapy, targeted radiotherapy, surgery)
with a history of psychiatric illness
with recurrent cancer of the cerebral nervous system
having begun first-line treatment (drug therapy, curative surgery, radiotherapy or palliative care)
under guardianship, curatorship or deprived of liberty
Parallel
Teleconsultation for psychological support
Other interventionTeleconsultation with a nurse for psychological support, after the diagnosis has been announced, before hospitalization for the first treatment (chemotherapy, surgery, radiotherapy) in addition to the standard practice
Distress thermometer
Comparison of the change in psychological distress score, measured using the psychological distress screening tool (from National Comprehensive Cancer Network) between the 2 groups between inclusion (T0) and before the first anti-cancer therapy (T1).
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
